Table 1.
Baseline features of focal autoimmune pancreatitis type 1 and pancreatic cancer patients included in the study
| f-AIP type 1 patients (n=15), n (%) | PC patients (n=60), n (%) | Univariate analysis (P) | |
|---|---|---|---|
| Age (years), median (range) | 68.8 (62.8-74.8) | 66.9 (64.1-69.6) | 0.53 |
| Sex | |||
| Male | 13 (86.6) | 46 (76.6) | 0.62 |
| Asymptomatic | 4 (26.6) | 10 (16.7) | 0.60 |
| Onset symptoms | |||
| Jaundice | 10 (66.7) | 32 (53.3) | 0.52 |
| Abdominal pain | 3 (20.0) | 15 (25.0) | 0.94 |
| New onset diabetes | 2 (13.3) | 6 (10.0) | 0.70 |
| Weight loss | 0 | 5 (8.3) | 0.56 |
| Biliary stent placement before EUS examination | 6 (40.0) | 17 (28.3) | 0.57 |
| Location focal mass | |||
| Head/uncinate process | 12 (80.0) | 48 (80.0) | 0.99 |
| Body/neck | 2 (13.3) | 8 (13.3) | 0.86 |
| Tail | 1 (6.7) | 4 (6.7) | 0.99 |
| Hypoechoic mass | 15 (100) | 60 (100) | 0.99 |
f-AIP: Focal autoimmune pancreatitis; PC: Pancreatic cancer